All seven members of 23andMe’s board resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the ...

Meta could face a significant fine from the European Union for attempting to dominate the classifieds ad market. Regulators ...

Led by CEO Wojcicki, 23andMe gives users insights into their genetic makeup with a saliva sample. In March, the company became the first to offer an FDA-approved home genetic test for cancer risk ...

All seven independent directors of 23andMe resigned from the company's board Tuesday, a move that CEO Anne Wojcicki said left her "surprised and disappointed," according to a memo to employees.

23andMe Holding Co. co-founder and Chief Executive Officer Anne Wojcicki told employees that she remains committed to taking the genetic testing company private following the resignation of its ...

Seven directors of 23andMe resigned from the genetic test company's board Tuesday amid co-founder and CEO Anne Wojcicki's attempt to buy out existing shareholders and take the company private.

DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests into homes with just a tube of spit. WSJ takes a look at the factors that have ...

Me's independent board members resigned after months of waiting for Anne Wojcicki's fully financed proposal to take the company private.

The genetic testing firm's shares were up 2.8% at $0.31 in extended trade. In July, Wojcicki, who has been trying to take the ...

Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.

In a memo to employees, CEO Anne Wojcicki said she was "surprised and disappointed by the decision." All seven independent directors of 23andMe resigned from the company's board Tuesday ...